Skip to main content

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) Investor Securities Class Action Lawsuit 03/30/2026

  • If you purchased a significant amount of shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, and / or if you purchased any NASDAQ: ALDX shares prior to November 2023 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: May 29, 2026. NASDAQ: ALDX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 30, 2026 - An investor in shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Aldeyra Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between November 3, 2023 and March 16, 2026.   Lexingtonm, MA based Ald...



You must register (for free) or login to view the entire case.